Fidelity Advisor Biotechnology Fund Manager Performance Evaluation

FBTAX Fund  USD 31.53  0.01  0.03%   
The fund shows a Beta (market volatility) of 0.88, which means possible diversification benefits within a given portfolio. Fidelity Advisor returns are very sensitive to returns on the market. As the market goes up or down, Fidelity Advisor is expected to follow.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fidelity Advisor Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
...more
Expense Ratio0.9600
  

Fidelity Advisor Relative Risk vs. Return Landscape

If you would invest  3,291  in Fidelity Advisor Biotechnology on September 1, 2024 and sell it today you would lose (138.00) from holding Fidelity Advisor Biotechnology or give up 4.19% of portfolio value over 90 days. Fidelity Advisor Biotechnology is currently producing negative expected returns and takes up 1.2646% volatility of returns over 90 trading days. Put another way, 11% of traded mutual funds are less volatile than Fidelity, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Fidelity Advisor is expected to under-perform the market. In addition to that, the company is 1.69 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.2 per unit of volatility.

Fidelity Advisor Current Valuation

Fairly Valued
Today
31.53
Please note that Fidelity Advisor's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Fidelity Advisor Bio shows a prevailing Real Value of $31.87 per share. The current price of the fund is $31.53. We determine the value of Fidelity Advisor Bio from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.
Since Fidelity Advisor is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fidelity Mutual Fund. However, Fidelity Advisor's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  31.53 Real  31.87 Hype  32.89 Naive  32.8
The intrinsic value of Fidelity Advisor's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fidelity Advisor's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
31.87
Real Value
33.13
Upside
Estimating the potential upside or downside of Fidelity Advisor Biotechnology helps investors to forecast how Fidelity mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fidelity Advisor more accurately as focusing exclusively on Fidelity Advisor's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
29.1430.5531.96
Details
Hype
Prediction
LowEstimatedHigh
28.3832.8934.15
Details
Naive
Forecast
LowNext ValueHigh
31.5432.8034.07
Details

Fidelity Advisor Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Fidelity Advisor's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Fidelity Advisor Biotechnology, and traders can use it to determine the average amount a Fidelity Advisor's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0475

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsFBTAX

Estimated Market Risk

 1.26
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.06
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Fidelity Advisor is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fidelity Advisor by adding Fidelity Advisor to a well-diversified portfolio.

Fidelity Advisor Fundamentals Growth

Fidelity Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Fidelity Advisor, and Fidelity Advisor fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fidelity Mutual Fund performance.

About Fidelity Advisor Performance

Evaluating Fidelity Advisor's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Fidelity Advisor has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fidelity Advisor has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

Things to note about Fidelity Advisor Bio performance evaluation

Checking the ongoing alerts about Fidelity Advisor for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Fidelity Advisor Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Fidelity Advisor Bio generated a negative expected return over the last 90 days
The fund retains 96.98% of its assets under management (AUM) in equities
Evaluating Fidelity Advisor's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Fidelity Advisor's mutual fund performance include:
  • Analyzing Fidelity Advisor's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fidelity Advisor's stock is overvalued or undervalued compared to its peers.
  • Examining Fidelity Advisor's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Fidelity Advisor's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fidelity Advisor's management team can help you assess the Mutual Fund's leadership.
  • Pay attention to analyst opinions and ratings of Fidelity Advisor's mutual fund. These opinions can provide insight into Fidelity Advisor's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Fidelity Advisor's mutual fund performance is not an exact science, and many factors can impact Fidelity Advisor's mutual fund market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Fidelity Mutual Fund

Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules